[SLN] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 0.00%
YoY- 205.12%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue -842 122 0 0 385 0 4 -
PBT -3,789 -6,636 -5,370 1,441 -2,410 -2,644 -3,178 2.97%
Tax -1,838 950 507 508 557 1,392 446 -
NP -1,951 -5,686 -4,862 1,949 -1,854 -1,252 -2,732 -5.45%
Tax Rate - - - -35.30% - - - -
Total Cost 1,109 5,808 4,862 -1,949 2,239 1,252 2,736 -13.96%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 231.71 -4,660.66 0.00 0.00 -481.43 0.00 -68,300.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.07 -0.22 -0.21 0.08 -0.08 -0.05 -0.16 -12.85%
EPS Diluted -0.07 -0.22 -0.21 0.08 -0.08 -0.05 -0.16 -12.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.